133 related articles for article (PubMed ID: 25039376)
21. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
[TBL] [Abstract][Full Text] [Related]
22. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
24. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
26. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
Schlitter AM; Born D; Bettstetter M; Specht K; Kim-Fuchs C; Riener MO; Jeliazkova P; Sipos B; Siveke JT; Terris B; Zen Y; Schuster T; Höfler H; Perren A; Klöppel G; Esposito I
Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas.
Sawada R; Ku Y; Akita M; Otani K; Fujikura K; Itoh T; Ajiki T; Fukumoto T; Kakeji Y; Zen Y
Histopathology; 2018 Aug; 73(2):259-272. PubMed ID: 29675965
[TBL] [Abstract][Full Text] [Related]
28. Cystic and micropapillary epithelial changes of peribiliary glands might represent a precursor lesion of biliary epithelial neoplasms.
Sato Y; Harada K; Sasaki M; Nakanuma Y
Virchows Arch; 2014 Feb; 464(2):157-63. PubMed ID: 24458517
[TBL] [Abstract][Full Text] [Related]
29. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
[TBL] [Abstract][Full Text] [Related]
30. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
31. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
34. Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.
Hoshino H; Ohta M; Ito M; Uchimura K; Sakai Y; Uehara T; Low S; Fukushima M; Kobayashi M
Lab Invest; 2016 Dec; 96(12):1246-1255. PubMed ID: 27748735
[TBL] [Abstract][Full Text] [Related]
35. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
[TBL] [Abstract][Full Text] [Related]
36. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma.
Wu WR; Shi XD; Zhang R; Zhu MS; Xu LB; Yu XH; Zeng H; Wang J; Liu C
Int J Clin Exp Pathol; 2014; 7(6):3272-9. PubMed ID: 25031748
[TBL] [Abstract][Full Text] [Related]
38. Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct.
Maeno S; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2012 May; 19(3):289-96. PubMed ID: 22179577
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
Aishima S; Oda Y
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
[TBL] [Abstract][Full Text] [Related]
40. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
